keyword
https://read.qxmd.com/read/38618577/histology-findings-after-two-years-of-cytology-hpv-co-testing-in-germany
#1
JOURNAL ARTICLE
Arjola Xhaja, André Ahr, Ilona Zeiser, Hans Ikenberg
INTRODUCTION: Since 1 January 2020, diagnostic confirmation of abnormalities detected in the context of cytology/HPV co-testing in cervical cancer screening under the statutory health insurance scheme in women aged 35 and over has been performed according to predefined algorithms. A colposcopy is indicated even in the case of borderline/low-grade cytological changes and/or HPV persistence. In this article we compare the histology findings after primary screening examinations in 2020/21 with those from 2018/19, thus also comparing the results of two different screening approaches...
April 2024: Geburtshilfe und Frauenheilkunde
https://read.qxmd.com/read/38602477/applications-of-data-characteristic-ai-assisted-raman-spectroscopy-in-pathological-classification
#2
JOURNAL ARTICLE
Xun Chen, Jianghao Shen, Chang Liu, Xiaoyu Shi, Weichen Feng, Hongyi Sun, Weifeng Zhang, Shengpai Zhang, Yuqing Jiao, Jing Chen, Kun Hao, Qi Gao, Yitong Li, Weili Hong, Pu Wang, Limin Feng, Shuhua Yue
Raman spectroscopy has been widely used for label-free biomolecular analysis of cells and tissues for pathological diagnosis in vitro and in vivo. AI technology facilitates disease diagnosis based on Raman spectroscopy, including machine learning (PCA and SVM), manifold learning (UMAP), and deep learning (ResNet and AlexNet). However, it is not clear how to optimize the appropriate AI classification model for different types of Raman spectral data. Here, we selected five representative Raman spectral data sets, including endometrial carcinoma, hepatoma extracellular vesicles, bacteria, melanoma cell, diabetic skin, with different characteristics regarding sample size, spectral data size, Raman shift range, tissue sites, Kullback-Leibler (KL) divergence, and significant Raman shifts (i...
April 11, 2024: Analytical Chemistry
https://read.qxmd.com/read/38596432/the-dna-damage-response-ddr-landscape-of-endometrial-cancer-defines-discrete-disease-subtypes-and-reveals-therapeutic-opportunities
#3
JOURNAL ARTICLE
Xingyuan Zhang, Sayali Joseph, Di Wu, Jessica L Bowser, Cyrus Vaziri
Genome maintenance is an enabling characteristic that allows neoplastic cells to tolerate the inherent stresses of tumorigenesis and evade therapy-induced genotoxicity. Neoplastic cells also deploy many mis-expressed germ cell proteins termed Cancer Testes Antigens (CTAs) to promote genome maintenance and survival. Here, we present the first comprehensive characterization of the DNA Damage Response (DDR) and CTA transcriptional landscapes of endometrial cancer in relation to conventional histological and molecular subtypes...
June 2024: NAR cancer
https://read.qxmd.com/read/38577616/glucose-metabolism-reprogramming-in-gynecologic-malignant-tumors
#4
REVIEW
Jianhong Ma, Zhiqiang Yao, Liangjian Ma, Qinyin Zhu, Jiajia Zhang, Ling Li, Chang Liu
The incidence and mortality of gynecological tumors are progressively increasing due to factors such as obesity, viral infection, unhealthy habits, as well as social and economic pressures. Consequently, it has emerged as a significant threat to women's health. Numerous studies have revealed the remarkable metabolic activity of tumor cells in glycolysis and its ability to influence malignant biological behavior through specific mechanisms. Therefore, it is crucial for patients and gynecologists to comprehend the role of glycolytic proteins, regulatory molecules, and signaling pathways in tumorigenesis, progression, and treatment...
2024: Journal of Cancer
https://read.qxmd.com/read/38562813/dysregulation-of-cell-state-dynamics-during-early-stages-of-serous-endometrial-carcinogenesis
#5
Andrea Flesken-Nikitin, Matalin G Pirtz, Christopher S Ashe, Lora H Ellenson, Benjamin D Cosgrove, Alexander Yu Nikitin
Serous endometrial carcinoma (SEC) constitutes about 10% of endometrial carcinomas and is one of the most aggressive and lethal types of uterine cancer. Due to the rapid progression of SEC, early detection of this disease is of utmost importance. However, molecular and cellular dynamics during the pre-dysplastic stage of this disease remain largely unknown. Here, we provide a comprehensive census of cell types and their states for normal, pre-dysplastic, and dysplastic endometrium in a mouse model of SEC. This model is associated with inactivation of tumor suppressor genes Trp53 and Rb1 , whose pathways are altered frequently in SEC...
March 19, 2024: bioRxiv
https://read.qxmd.com/read/38546950/establishment-and-characterization-of-multiple-patient-derived-organoids-from-a-case-of-advanced-endometrial-cancer
#6
JOURNAL ARTICLE
Yoshiaki Maru, Mami Kohno, Kiyomi Suzuka, Akiko Odaka, Mari Masuda, Akinobu Araki, Makiko Itami, Naotake Tanaka, Yoshitaka Hippo
Patient-derived organoids (PDOs) retain the original tumor's characteristics to a large degree and allow direct evaluation of the drug sensitivity, thereby emerging as a valuable resource for both basic and preclinical researches. Whereas most past studies stereotypically adopted a single PDO as an avatar of the patient, it remains to be investigated whether this assumption can be justified even for the tumor with spatial diversity. To address this issue, we established and characterized multiple PDOs originating from various sites of a patient with advanced uterine carcinosarcoma (UCS)...
March 28, 2024: Human Cell
https://read.qxmd.com/read/38529651/prediction-of-lymphovascular-space-invision-in-endometrial-cancer-based-on-multi-parameter-mri-radiomics-model
#7
JOURNAL ARTICLE
Jin Jun Wang, Xiao Hong Zhang, Xing Hua Guo, Yang Ying, Xiang Wang, Zhong Hua Luan, Wei Qin Lv, Peng Fei Wang
UNLABELLED: <p>Objective: To explore the application value of a combined model based on multi-parameter MRI radiomics and clinical features in preoperative prediction of lymphatic vascular space invasion (LVSI) in endometrial carcinoma (EC). METHODS: This retrospective study collected the clinicopathological and imaging data of 218 patients with EC in Yuncheng Central Hospital from March 2018 to May 2022. The patients were randomly divided into training group (n=152) and validation group (n= 66) according to the ratio of 7: 3...
March 19, 2024: Current medical imaging
https://read.qxmd.com/read/38518807/interaction-between-xrcc2-gene-polymorphism-and-abdominal-obesity-on-risk-of-endometrial-carcinoma
#8
JOURNAL ARTICLE
Wenjuan Tian, Siyu Cao, Wei Zhang, Chenlian Quan, Meiqin Zhang, Yan Huang
AIMS: The aim of this study was to investigate the impact of three single nucleotide polymorphisms (SNPs) within X-Ray Repair Cross Complementary Group 2 (XRCC2) gene and additional gene- abdominal obesity (AO) interaction with endometrial carcinoma (EC) risk. METHODS: Hardy-Weinberg equilibrium was tested for all participants by using SNPstats (online software: https://bioinfo.iconcologia.net/SNPstats). The best SNP-SNP and gene-AO interaction combination among three SNPs within XRCC2 gene and AO was screened using generalized multifactor dimensionality reduction (GMDR)...
February 12, 2024: Gynecological Endocrinology
https://read.qxmd.com/read/38513273/morules-and-%C3%AE-catenin-predict-pole-mutation-status-in-endometrial-cancer-a-pathway-to-more-cost-effective-diagnostic-procedures
#9
JOURNAL ARTICLE
Rujia Fan, Wanrun Lin, Ruijiao Zhao, Li Li, Rui Xin, Yunfeng Zhang, Yuxin Liu, Ying Ma, Yiying Wang, Yue Wang, Wenxin Zheng
OBJECTIVES: The characterization of DNA polymerase epsilon (POLE) mutations has transformed the classification of endometrial endometrioid carcinomas (EECs), highlighting the need for efficient identification methods. This study aims to examine the relationship between distinct morphologic features-namely, squamous morules and squamous differentiation (SD), as well as β-catenin expression-and the POLE mutation status in endometrial cancer (EC). METHODS: Our study included 35 POLE-mutated (POLEmut) EC cases and 395 non-POLEmut EEC cases...
March 21, 2024: American Journal of Clinical Pathology
https://read.qxmd.com/read/38504572/advances-in-mirnas-involved-in-endometrial-carcinoma
#10
JOURNAL ARTICLE
Yan He, Ke Liao, Hua Peng, Xiangman Zou, Zifen Guo
Endometrial carcinoma (EC) is a common malignancy worldwide. Existing evidence has revealed that EC could be associated with abnormal gene expression. Meantime, evidence supports that miRNAs act as critical regulators in gene expression through the binding to the 3'- untranslated region (3'-UTR). Accordingly, this review concludes some recent studies focusing on miRNAs that influence EC, aiming at understanding the association between miRNAs and EC more clearly and providing a reference for further studies on miRNA-related drugs treating EC...
March 19, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38484694/postmenopausal-endometrial-non-benign-lesion-risk-classification-through-a-clinical-parameter-based-machine-learning-model
#11
JOURNAL ARTICLE
Jin Lai, Bo Rao, Zhao Tian, Qing-Jie Zhai, Yi-Ling Wang, Si-Kai Chen, Xin-Ting Huang, Hong-Lan Zhu, Heng Cui
OBJECTIVE: This study aimed to develop and evaluate a machine learning model utilizing non-invasive clinical parameters for the classification of endometrial non-benign lesions, specifically atypical hyperplasia (AH) and endometrioid carcinoma (EC), in postmenopausal women. METHODS: Our study collected clinical parameters from a cohort of 999 patients with postmenopausal endometrial lesions and conducted preprocessing to identify 57 relevant characteristics from these irregular clinical data...
March 7, 2024: Computers in Biology and Medicine
https://read.qxmd.com/read/38482446/function-of-homocysteine-and-he4-in-endometrial-carcinoma-verified-by-prospective-experiment
#12
JOURNAL ARTICLE
Zhaoxia Yang, Jianyun Zhou, Jiacong Wu, Guangquan Liu, Qinghua Xi
BACKGROUND: Timely diagnosis is the key factor to improve the prognosis of endometrial carcinoma (EC). To date, no particularly good markers could significantly improve the detection rate of EC. This study aimed to assess the utility of serum markers homocysteine (Hcy), human epididymal protein 4 (HE4), cancer antigen 199 (CA199), cancer antigen 125 (CA125), fibrinogen (Fib), and D-dimer (D-D) for EC diagnosis, especially Hcy of which its role in EC has not been noticed. METHODS: Pre-test and verification tests were performed...
February 29, 2024: Translational Cancer Research
https://read.qxmd.com/read/38462350/-prevention-and-treatment-of-endometrial-cancer
#13
JOURNAL ARTICLE
B H Kong, K Song, A J Yin
Endometrial cancer is rising in incidence, especially in young women. This rise in incidence has implications for both primary prevention and screening in high-risk population. In the past several years, our understanding of the integration of clinically related genomic and pathologic data optimized the management of endometrial cancer. The updated 2023 FIGO staging includes the histological and molecular classification to better reflect the improved understanding of the heterogenous nature of endometrial carcinoma...
March 12, 2024: Zhonghua Yi Xue za Zhi [Chinese medical journal]
https://read.qxmd.com/read/38405483/identifying-the-main-components-and-mechanisms-of-action-of-artemisia-annua-l-in-the-treatment-of-endometrial-cancer-using-network-pharmacology
#14
JOURNAL ARTICLE
Weikang Guo, Wanyue Wang, Fei Lei, Ruxin Zheng, Xinyao Zhao, Yuze Gu, Mengdi Yang, Yunshun Tong, Yaoxian Wang
Artemisia annua L. ( A. annua ), a Traditional Chinese Medicine (TCM) that has been utilized in China for centuries, is known for its potential anticancer properties. However, the main components and mechanism of action of A. annua on endometrial carcinoma have not been reported. We used the TCMSP database to identify the active components of A. annua and their corresponding gene targets. We then obtained the gene targets specific to endometrial cancer from The Cancer Genome Atlas (TCGA) and GeneCards databases...
February 20, 2024: ACS Omega
https://read.qxmd.com/read/38355782/a-novel-immune-related-gene-signature-for-diagnosis-and-potential-immunotherapy-of-microsatellite-stable-endometrial-carcinoma
#15
JOURNAL ARTICLE
Yunyun Xiao, XiaoChuan Yu, Yaping Wang, Guangyao Song, Ming Liu, Daqing Wang, Huali Wang
An immune-related gene signature (IRGS) was established to better understand the molecular and immunologic characteristics of microsatellite instable (MSI) and microsatellite stable (MSS) endometrial carcinoma (EC), and provide potential immunotherapy directions for MSS patients. Top 20 immune-related hub genes were screened by weight gene coexpression network analysis (WGCNA), and an IRGS was further established through Cox regression analysis. The molecular and immune characteristics were clarified in IRGS high and low risk groups...
February 14, 2024: Scientific Reports
https://read.qxmd.com/read/38336274/identification-and-validation-of-kif23-as-a-hypoxia-regulated-lactate-metabolism-related-oncogene-in-uterine-corpus-endometrial-carcinoma
#16
JOURNAL ARTICLE
Tao Wang, Xiaotong Peng, Wenwen Liu, Mei Ji, Jing Sun
AIMS: The "Warburg effect" has been developed from the discovery that hypoxia-inducible factor 1α (HIF-1α) could promote the conversion of pyruvate to lactate. However, no studies have linked hypoxia and lactate metabolism to uterine corpus endometrial carcinoma (UCEC). MAIN METHODS: Sequencing and clinical data of patients with UCEC were extracted from The Cancer Genome Atlas (TCGA) database. Hypoxia-related lactate metabolism genes (HRLGs) were screened using Spearman's correlation analysis...
February 7, 2024: Life Sciences
https://read.qxmd.com/read/38328458/recurrent-colon-cancer-in-a-patient-with-muir-torre-syndrome-a-case-report
#17
Angeline C Rivkin, Philip Bystrom, Amy Y Lin, Vivek Chaudhry
Muir-Torre syndrome (MTS) is a rare subtype of hereditary nonpolyposis colorectal cancer syndrome caused by a defect in DNA mismatch repair leading to microsatellite instability. It is characterized by the presence of at least one sebaceous gland tumor and one internal malignancy, most commonly colorectal and endometrial tumors. These patients have a high propensity for tumorigenesis, and while strict screening protocols are in place, there are only two cases that describe the management approach to recurrent colon cancer...
February 2024: Journal of Surgical Case Reports
https://read.qxmd.com/read/38279277/epha2-and-hdac-targeted-combination-therapy-in-endometrial-cancer
#18
JOURNAL ARTICLE
Robiya Joseph, Santosh K Dasari, Sujanitha Umamaheswaran, Lingegowda S Mangala, Emine Bayraktar, Cristian Rodriguez-Aguayo, Yutuan Wu, Nghi Nguyen, Reid T Powell, Mary Sobieski, Yuan Liu, Mark Seungwook Kim, Sara Corvigno, Katherine Foster, Pahul Hanjra, Thanh Chung Vu, Mamur A Chowdhury, Paola Amero, Clifford Stephan, Gabriel Lopez-Berestein, Shannon N Westin, Anil K Sood
Endometrial cancer is the most frequent malignant tumor of the female reproductive tract but lacks effective therapy. EphA2, a receptor tyrosine kinase, is overexpressed by various cancers including endometrial cancer and is associated with poor clinical outcomes. In preclinical models, EphA2-targeted drugs had modest efficacy. To discover potential synergistic partners for EphA2-targeted drugs, we performed a high-throughput drug screen and identified panobinostat, a histone deacetylase inhibitor, as a candidate...
January 20, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38231050/tomm40-correlates-with-cholesterol-and-is-predictive-of-a-favorable-prognosis-in-endometrial-carcinoma
#19
JOURNAL ARTICLE
Yan Chen, Yi Luo, Jinling Long, Siyun Liu, Linbeini Zhao, Baishu Chen, Qiuyun Mu
BACKGROUND: A link between cholesterol and endometrial cancer has been established, but current studies have been limited in their findings. We aimed to elucidate the causal relationship between cholesterol and endometrial cancer and to find prognostic genes for endometrial cancer. METHODS: We first explored the causal relationship between total cholesterol and endometrial cancer using two-sample Mendelian randomization and then obtained differential genes to screen for prognosis-related genes in endometrial cancer...
January 12, 2024: Combinatorial Chemistry & High Throughput Screening
https://read.qxmd.com/read/38206110/utilizing-pten-immunohistochemistry-as-a-screening-test-for-cowden-syndrome
#20
JOURNAL ARTICLE
Emily Hartsough, Mia S DeSimone, Mayra E Lorenzo, Dora Dias-Santagata, Vania Nose, Mai P Hoang
OBJECTIVES: Cowden syndrome (CS) is a multisystem disease with an elevated lifetime risk of internal malignancy. We aim to assess the role of PTEN immunostain as a screening test for CS in a variety of common CS-associated neoplasms, with a particular focus on cutaneous tumors. METHODS: We retrospectively searched for patients meeting criteria for CS and/or demonstrating germline PTEN mutation from 2008 to 2022. We then performed PTEN immunostains on tumors of these patients as well as control cases...
January 11, 2024: American Journal of Clinical Pathology
keyword
keyword
37707
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.